Given the association of severe malaria with excessive TH1 inflammatory responses, it is reasonable to hypothesize that CHI3L1 levels would be increased in severe malaria infection, and would protect against immunopathology in experimental CM (ECM). Here, CHI3L1 is linked to malaria.